SNANF

SONA NANOTECH INC by Sona Nanotech Inc (SNANF)

About SONA NANOTECH INC by Sona Nanotech Inc (SNANF)

Sona Nanotech, Inc. engages in the development of multiple proprietary methods for the manufacture of various types of gold nanoparticles in medical applications. It is involved in developing targeted hyperthermia, a photothermal cancer therapy, which uses therapeutic heat to treat solid cancer tumors. The company was founded by Gerrard Marangoni, Kulbir Singh, and Michael McAlduff on November 17, 2004 and is headquartered in Halifax, Canada.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.43
52 Week Low
$0.16
Market cap
44.7M
Dividend yield
0.00%
Volume
5
Avg. volume
15,821
P/E ratio
-20.05

SONA NANOTECH INC by Sona Nanotech Inc News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.43
52 Week Low
$0.16
Market cap
44.7M
Dividend yield
0.00%
Volume
5
Avg. volume
15,821
P/E ratio
-20.05